Genocea Biosciences Co-Founder Receives TIME Magazine’s TIME 100 Honor
4/24/2014 9:51:25 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, Inc. (NASDAQ: GNCA), a clinical-stage biopharmaceutical company developing T cell-enabled vaccines and immunotherapies, today announced that TIME magazine has named company co-founder David A. Sinclair, Ph.D., to the 2014 TIME 100, its annual list of the 100 most influential people in the world. Recognized for his breakthroughs in aging research, Dr. Sinclair currently serves as a Professor of Genetics and co-Director of the Paul F. Glenn Laboratories for the Biological Mechanisms of Aging at Harvard Medical School.
Help employers find you! Check out all the jobs and post your resume.
comments powered by